Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas

Stefan Moldovan, Azmi Atiya, Thomas E. Adrian, Robert M. Kleinman, Kevin C K Lloyd, Kim Olthoff, David Imagawa, Linda Shevlin, David Coy, John Walsh, F. Charles Brunicardi

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Recently five somatostatin receptor subtypes (SSTR) have been cloned, allowing the development of highly specific selective agonists for these SSTR. The present study was undertaken to determine which SSTR is responsible for the inhibitory effect of somatostatin on islet hormone secretion. Single-pass perfusion of four agonists was performed in pancreata obtained from four cadaveric organ donors using a modified Krebs-media with 3.9 mM glucose. Sequential 10-min specific receptor agonist infusions (5 ng/ml) of DC32-87 (SSTR2), DC25-12 (SSTR3), DC32-97 (SSTR3), or DC32-92 (SSTR5) were performed in random order separated by 10-min basal periods. Infusion of SSTR2 agonist into the isolated per fused human pancreas resulted in a significant inhibition of insulin and C-peptide secretion (insulin = -1468 ± 480 pM, P < 0.05, and C-peptide = -2328 ± 437 pM, P < 0.05) but not islet amyloid polypeptide or somatostatin. These results suggest that the inhibitory effect of somatostatin on B-cell secretion is mediated through the subtype-2 receptor within the human islet.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalJournal of Surgical Research
Volume59
Issue number1
DOIs
StatePublished - Jul 1995
Externally publishedYes

Fingerprint

Somatostatin Receptors
Somatostatin
Pancreas
B-Lymphocytes
C-Peptide
Insulin
Islet Amyloid Polypeptide
Perfusion
Tissue Donors
Hormones
Glucose
somatostatin receptor 2

ASJC Scopus subject areas

  • Surgery

Cite this

Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas. / Moldovan, Stefan; Atiya, Azmi; Adrian, Thomas E.; Kleinman, Robert M.; Lloyd, Kevin C K; Olthoff, Kim; Imagawa, David; Shevlin, Linda; Coy, David; Walsh, John; Brunicardi, F. Charles.

In: Journal of Surgical Research, Vol. 59, No. 1, 07.1995, p. 85-90.

Research output: Contribution to journalArticle

Moldovan, S, Atiya, A, Adrian, TE, Kleinman, RM, Lloyd, KCK, Olthoff, K, Imagawa, D, Shevlin, L, Coy, D, Walsh, J & Brunicardi, FC 1995, 'Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas', Journal of Surgical Research, vol. 59, no. 1, pp. 85-90. https://doi.org/10.1006/jsre.1995.1136
Moldovan, Stefan ; Atiya, Azmi ; Adrian, Thomas E. ; Kleinman, Robert M. ; Lloyd, Kevin C K ; Olthoff, Kim ; Imagawa, David ; Shevlin, Linda ; Coy, David ; Walsh, John ; Brunicardi, F. Charles. / Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas. In: Journal of Surgical Research. 1995 ; Vol. 59, No. 1. pp. 85-90.
@article{60d50965675e4d858f5e2acc594d0cad,
title = "Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas",
abstract = "Recently five somatostatin receptor subtypes (SSTR) have been cloned, allowing the development of highly specific selective agonists for these SSTR. The present study was undertaken to determine which SSTR is responsible for the inhibitory effect of somatostatin on islet hormone secretion. Single-pass perfusion of four agonists was performed in pancreata obtained from four cadaveric organ donors using a modified Krebs-media with 3.9 mM glucose. Sequential 10-min specific receptor agonist infusions (5 ng/ml) of DC32-87 (SSTR2), DC25-12 (SSTR3), DC32-97 (SSTR3), or DC32-92 (SSTR5) were performed in random order separated by 10-min basal periods. Infusion of SSTR2 agonist into the isolated per fused human pancreas resulted in a significant inhibition of insulin and C-peptide secretion (insulin = -1468 ± 480 pM, P < 0.05, and C-peptide = -2328 ± 437 pM, P < 0.05) but not islet amyloid polypeptide or somatostatin. These results suggest that the inhibitory effect of somatostatin on B-cell secretion is mediated through the subtype-2 receptor within the human islet.",
author = "Stefan Moldovan and Azmi Atiya and Adrian, {Thomas E.} and Kleinman, {Robert M.} and Lloyd, {Kevin C K} and Kim Olthoff and David Imagawa and Linda Shevlin and David Coy and John Walsh and Brunicardi, {F. Charles}",
year = "1995",
month = "7",
doi = "10.1006/jsre.1995.1136",
language = "English (US)",
volume = "59",
pages = "85--90",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas

AU - Moldovan, Stefan

AU - Atiya, Azmi

AU - Adrian, Thomas E.

AU - Kleinman, Robert M.

AU - Lloyd, Kevin C K

AU - Olthoff, Kim

AU - Imagawa, David

AU - Shevlin, Linda

AU - Coy, David

AU - Walsh, John

AU - Brunicardi, F. Charles

PY - 1995/7

Y1 - 1995/7

N2 - Recently five somatostatin receptor subtypes (SSTR) have been cloned, allowing the development of highly specific selective agonists for these SSTR. The present study was undertaken to determine which SSTR is responsible for the inhibitory effect of somatostatin on islet hormone secretion. Single-pass perfusion of four agonists was performed in pancreata obtained from four cadaveric organ donors using a modified Krebs-media with 3.9 mM glucose. Sequential 10-min specific receptor agonist infusions (5 ng/ml) of DC32-87 (SSTR2), DC25-12 (SSTR3), DC32-97 (SSTR3), or DC32-92 (SSTR5) were performed in random order separated by 10-min basal periods. Infusion of SSTR2 agonist into the isolated per fused human pancreas resulted in a significant inhibition of insulin and C-peptide secretion (insulin = -1468 ± 480 pM, P < 0.05, and C-peptide = -2328 ± 437 pM, P < 0.05) but not islet amyloid polypeptide or somatostatin. These results suggest that the inhibitory effect of somatostatin on B-cell secretion is mediated through the subtype-2 receptor within the human islet.

AB - Recently five somatostatin receptor subtypes (SSTR) have been cloned, allowing the development of highly specific selective agonists for these SSTR. The present study was undertaken to determine which SSTR is responsible for the inhibitory effect of somatostatin on islet hormone secretion. Single-pass perfusion of four agonists was performed in pancreata obtained from four cadaveric organ donors using a modified Krebs-media with 3.9 mM glucose. Sequential 10-min specific receptor agonist infusions (5 ng/ml) of DC32-87 (SSTR2), DC25-12 (SSTR3), DC32-97 (SSTR3), or DC32-92 (SSTR5) were performed in random order separated by 10-min basal periods. Infusion of SSTR2 agonist into the isolated per fused human pancreas resulted in a significant inhibition of insulin and C-peptide secretion (insulin = -1468 ± 480 pM, P < 0.05, and C-peptide = -2328 ± 437 pM, P < 0.05) but not islet amyloid polypeptide or somatostatin. These results suggest that the inhibitory effect of somatostatin on B-cell secretion is mediated through the subtype-2 receptor within the human islet.

UR - http://www.scopus.com/inward/record.url?scp=0029150492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029150492&partnerID=8YFLogxK

U2 - 10.1006/jsre.1995.1136

DO - 10.1006/jsre.1995.1136

M3 - Article

C2 - 7630142

AN - SCOPUS:0029150492

VL - 59

SP - 85

EP - 90

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -